The endocannabinoid anandamide activates pro‐resolving pathways in human primary macrophages by engaging both CB2 and GPR18 receptors
Article in The FASEB Journal (May 2024)
The most recent citing publications are shown below. View all 20 publications that cite this research output on Dimensions.
Article in The FASEB Journal (May 2024)
Article in Journal of Ocular Pharmacology and Therapeutics (April 2024)
Article in Ból (March 2024)